Examples of successful ADCs include those targeting nectin-4 in urothelial carcinoma and targeting trophoblast cell-surface antigen 2 (TROP-2) in breast cancer and urothelial carcinoma [41,42,43]. This evidence concerns the gene NECTIN4 and urothelial carcinoma.